Search for Clinical Trial Results
Hyperlipoproteinemias - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia Condition: Type 1 Hyperlipoproteinemia Date: 2012-08-27 Interventions:
|
Recruiting |
Study Name: Orlistat for the Treatment of Type I Hyperlipoproteinemia Condition:
Date: 2016-05-02 Interventions: Drug: Orlistat Orlistat is a gastric and pancreatic lipase inhibitor that is approved by the FDA for wei |
Completed |
Study Name: Type III Dysbetalipoproteinemia Condition: Hyperlipoproteinemia Type III Date: 2005-09-21 Interventions:
|
Terminated |
Study Name: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. Condition: Hyperlipoproteinemia Type III Date: 2005-08-31 Interventions:
|
Withdrawn |
Study Name: Efficacy Study of Daily Pro-Omega LDL for Low-Density Lipoprotein Cholesterol and Triglyceride Reduction Condition: Mixed Hyperlipoproteinemia Date: 2014-02-20 Interventions:
|
Terminated |
Study Name: Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies Condition: Hyperlipoproteinemia Type I Date: 2011-09-28 |
Completed |
Study Name: Plasma Triglyceride Lipolysis in Multifactorial Chylomicronemia Condition: Hyperlipoproteinemia Date: 2016-10-12 |
Completed |
Study Name: Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia Condition: Hyperlipoproteinemia Date: 2010-06-09 Interventions:
|
Completed |
Study Name: The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-08-16 Interventions:
|
Completed |
Study Name: Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia Condition: Hyperlipoproteinemia Date: 2013-06-10 Interventions:
|